Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ibotta To Contact Him Directly To Discuss Their Options

image for news SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ibotta

AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.

image for news AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151286&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

image for news Securities Fraud Class Action Filed Against DoubleVerify Holdings, Inc. (DV) - Levi & Korsinsky Reminds Investors of July 21, 2025

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Digimarc Corporation of Class Action Lawsuit and Upcoming Deadlines - DMRC

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.

image for news SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151287&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.

image for news Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)

Boeing's stock could rise 25%, BofA analysts said, as the aerospace and defense giant works to break out of its “doom loop.”

image for news Boeing CEO Ortberg is winning hearts on Wall Street. Here's the latest vote of confidence.

Shareholders led by two Michigan pension funds accused Google executives and directors of breaching their fiduciary duties by exposing the company to antitrust liability related to its search, Ad Tech, Android and app distribution businesses.

image for news Google to spend $500M to revamp compliance structure after shareholders seek ‘culture change'

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech — Positive

BMY  BNTX   CNBC Television — June 02, 2025

Christopher Boerner, CEO of Bristol Myers Squibb, said Monday that the company's $11 billion cancer drug partnership with BioNTech could be "the next new frontier in the treatment of cancer." The companies will work on transforming outcomes for patients with difficult-to-treat solid tumors, Boerner said.

image for news Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

Lowe's Rewards Shareholders With 4% Increase in Quarterly Dividend — Positive

LOW   Zacks Investment Research — June 02, 2025

LOW boosts its quarterly dividend by 4% to $1.20, signaling strong financials and a steady focus on shareholder value.

image for news Lowe's Rewards Shareholders With 4% Increase in Quarterly Dividend

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

Transaction in Own Shares — Neutral

SHEL   GlobeNewsWire — June 02, 2025

Transaction in Own Shares 2 June, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 2 June, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 02/06/2025 426,488 £24.8500 £24.4450 £24.6990 LSE GBP 02/06/2025 132,159 £24.8500 £24.4500 £24.6990 Chi-X (CXE) GBP 02/06/2025 76,353 £24.8450 £24.4800 £24.6987 BATS (BXE) GBP 02/06/2025 389,942 €29.6000 €29.1450 …

image for news Transaction in Own Shares

Vertiv delivered a robust Q1 2025 with 24.2% YoY revenue growth, driven by strength in the Americas and APAC, while adjusted EPS rose to $0.64. Robust backlog and continued order strength expected to support double-digit consolidated topline growth in 2025, despite EMEA softness. Near-term tariff pressure may weigh on Q2 margins, but execution and efficiency gains should support expansion beyond 2025.

image for news Vertiv: Even After A 60% Surge, Solid Q1'25 Earnings And Backlog Keep It A Buy

Nu Skin Enterprises Appoints James Winett to Board of Directors — Neutral

NUS   Business Wire — June 02, 2025

PROVO, Utah--(BUSINESS WIRE)---- $NUS--Nu Skin Enterprises (NUS: NYSE) today announced the appointment of James Winett, a managing member of SIZE Advisory Group, to the company's board of directors. He was elected by shareholders at the annual shareholder meeting for Nu Skin Enterprises. “Jim adds extensive expertise in strategic planning, operations and finance from his many years of consulting experience,” said Steven J. Lund, executive chairman of the board. “He will also be an asset to our Rhyz busi.

image for news Nu Skin Enterprises Appoints James Winett to Board of Directors

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE: ECG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Civitas To Contact Him Directly To Discuss Their Options

image for news SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources

More office space is set to be removed than added this year, shrinking the overall office footprint. Office vacancies soared to a record high and still hover right around there at 19%.

image for news More office space is being removed than added for the first time in at least 25 years

Wall street veteran sees massive S&P 500 rally ahead — Positive

IVV  SPLG  SPXL  SPY  SSO  UPRO  VOO   The Street — June 02, 2025

As Wall Street grows more cautious, this analyst sees the S&P 500 surging over the next six months. Transcript: Brett Ewing: My outlook for the S&P 500 over the next six months is probably on the higher end.

image for news Wall street veteran sees massive S&P 500 rally ahead

BIG3 and iHeartMedia Announce Multiplatform Partnership — Neutral

IHRT   Business Wire — June 02, 2025

LOS ANGELES--(BUSINESS WIRE)--Today the BIG3 announced a partnership with iHeartMedia, the #1 audio company in the U.S., that will bring BIG3 games and content to new audiences through iHeartMedia's expansive multiplatform network; and names iHeartRadio – the all-in-one digital music, podcasting and live streaming radio service – the audio home of BIG3 games. The league's eighth season tips off on Saturday, June 14, 2025 in Chicago, IL at Allstate Arena at 4pm ET live on CBS with play-by-play o.

image for news BIG3 and iHeartMedia Announce Multiplatform Partnership